Weight-loss Injections

The podcast investigates the efficacy, safety, and accessibility of weight loss injections, particularly Mounjaro. It explores how these drugs, modified versions of natural gut hormones, affect feelings of fullness and subsequent weight loss. The discussion covers the differences between semaglutide (Ozempic, Wegovy) and terzepatide (Mounjaro), including their effectiveness and side effects. Professor Giles Yeo, a molecular neuroendocrinologist, provides expert insights into the science behind the drugs, addressing listener questions about long-term use, potential health benefits beyond weight loss, and the importance of medical supervision. The high cost and unequal access to these medications, with most prescriptions being private, are also highlighted as major concerns.